Procter & Gamble Stock Steady as Restructuring Costs Loom

Procter & Gamble stock is holding steady near $145 as investors digest the company's fiscal 2026 results, which showed steady growth but also outlined a major restructuring program with costs ranging from $1 billion to $1.6 billion.

The program, aimed at streamlining operations and trimming organic growth by 0.3 to 0.5 percentage points in fiscal 2027, has already had an impact on current-period results, with $455 million in related expenses booked in the nine months ended March 2026.

Looking ahead, Procter & Gamble set its fiscal 2027 core EPS guidance in a range from $6.89 to $7.11 per share, which is relatively modest compared to some peers and aligns with analysts' expectations.